clinical

Videos

Prof. Giovanni Staurenghi, chairman of the University Eye Clinic, Department of Biomedical and Clinical Sciences at the University of Milan’s Luigi Sacco Hospital, Italy, discusses his presentation from this year's AAO, including findings from the HARBOR study of macular atrophy in AMD patients treated with ranibizumab.

AAO 2020: Considerations when using anti-VEGF for treating AMD

Articles

Modifier-25 same-day examinations are critical to the successful treatment and overall health and well being of these patients.

Same-day exams with anti-VEGF therapy key to QoL, cost savings for wet AMD 

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Study points to the possible role of addressing preprocedural anxiety

Easing patient comfort, pain perception of intravitreal injections

Investigators find that nanoparticles deliver gene therapy successfully in mice, rats

Taking a deeper dive: Novel gene therapy approaches to treat ocular disease

Agreement would include global rights for investigational treatment, risuteganib, expected to help reverse vision loss due to dry AMD

Bausch Health to acquire option to purchase ophthalmology assets of Allegro 

Intravitreal gene therapy continues to be well tolerated; shows robust efficacy

Targeting AMD patient treatment burden

Though OCTA has become indispensable for managing macular degeneration and diabetic retinopathy, Robert L. Stamper, MD, explains why the technology must become more sophisticated and evolved before it reaches its full potential for glaucoma specialists.

OCTA: Why the jury may still be out

Interim data update from first cohort using suprachoroidal delivery of RGX-314 expected by end of 2020 

Regenxbio: Dosing of first patient in Phase 2 AAVIATE trial for wet AMD 

Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.

Results of a prospective trial show the tool is ready for clinical use and potential deployment for remote telemedical use.

Deep learning algorithm proving accurate for AMD classification

A study suggests this user-friendly platform may be useful as a supplemental visual function measure in patients with AMD.